Reports Summarize Personalized Medicine Study Results from Capital Medical University (MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker)

Press/Media: Research

PeriodFeb 27 2025

Media coverage

1

Media coverage

  • TitleReports Summarize Personalized Medicine Study Results from Capital Medical University (MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker)
    Media name/outletClinical Oncology Daily
    Country/TerritoryUnited States
    Date27/2/25
    PersonsYang Yang
View all 1
View less